Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03099863 · ClinicalTrials.gov registry record · Phase 4
Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection
A Phase 4 study, sponsored by MetroHealth Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 242
- Enrollment target
NCT03099863 is a Phase 4 study that has completed, run by MetroHealth Medical Center. The registered enrollment target is 242 participants.
The verdict
NCT03099863, a Phase 4 study, has completed, sponsored by MetroHealth Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 242 participants
- Enrollment target
Study Summary
Postoperative urinary tract infections (UTIs) affect 20-30% of patients undergoing elective gynecologic surgery and have a significant socioeconomic impact and cost. Preoperative antibiotics, sterile operating techniques, postoperative antibiotic and non-antibiotic medical therapies have been utilized to attempt to decrease this rate with little improvement. Utilization of an intraoperative antibiotic cystoscopic irrigant may decrease postoperative UTIs. The investigators have designed a prospective randomized controlled study to evaluate the effectiveness of an antibiotic cystoscopic fluid in preventing postoperative urinary tract infections in women undergoing elective pelvic floor surgery with cystoscopy.
Interventions
- PROCEDURE Cystoscopy
- DRUG Cystoscopic Fluid containing Neosporin G. U. Irrigant
- DRUG Cystoscopic Fluid/Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2016-04 |
| Est. Completion | 2020-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03099863
The ClinicalTrials.gov registry entry for NCT03099863 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 242 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MetroHealth Medical Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cystoscopy is the first listed.
NCT03099863 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03099863 about?
NCT03099863 is a clinical study titled "Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection". Postoperative urinary tract infections (UTIs) affect 20-30% of patients undergoing elective gynecologic surgery and have a significant socioeconomic impact and cost. Preoperative antibiotics, sterile operating techniques, postoperative antibiotic and non-antibiotic medical therapies have been utiliz...
What is the current status of trial NCT03099863?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 242 participants. The study started on 2016-04. Estimated completion is 2020-06.
What interventions are being tested in trial NCT03099863?
The interventions under investigation include: Cystoscopy (PROCEDURE), Cystoscopic Fluid containing Neosporin G. U. Irrigant (DRUG), Cystoscopic Fluid/Placebo (DRUG).
Who is sponsoring clinical trial NCT03099863?
This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.